315 related articles for article (PubMed ID: 18430438)
1. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.
Fuller SJ; Sivarajah K; Sugden PH
J Mol Cell Cardiol; 2008 May; 44(5):831-54. PubMed ID: 18430438
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
3. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
4. The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R
Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
[TBL] [Abstract][Full Text] [Related]
5. Interaction and inhibitory cross-talk between endothelin and ErbB receptors in the adult heart.
Chung KY; Walker JW
Mol Pharmacol; 2007 Jun; 71(6):1494-502. PubMed ID: 17332141
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
Friedländer E; Arndt-Jovin DJ; Nagy P; Jovin TM; Szöllosi J; Vereb G
Cytometry A; 2005 Oct; 67(2):161-71. PubMed ID: 16163699
[TBL] [Abstract][Full Text] [Related]
7. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
Zhan L; Xiang B; Muthuswamy SK
Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction and oncogenesis by ErbB/HER receptors.
Marmor MD; Skaria KB; Yarden Y
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):903-13. PubMed ID: 14967450
[TBL] [Abstract][Full Text] [Related]
9. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.
Lidke DS; Nagy P; Heintzmann R; Arndt-Jovin DJ; Post JN; Grecco HE; Jares-Erijman EA; Jovin TM
Nat Biotechnol; 2004 Feb; 22(2):198-203. PubMed ID: 14704683
[TBL] [Abstract][Full Text] [Related]
10. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide.
Price KA; Filiz G; Caragounis A; Du T; Laughton KM; Masters CL; Sharples RA; Hill AF; Li QX; Donnelly PS; Barnham KJ; Crouch PJ; White AR
Int J Biochem Cell Biol; 2008; 40(9):1901-17. PubMed ID: 18346929
[TBL] [Abstract][Full Text] [Related]
11. erbB genes in the mouse uterus: cell-specific signaling by epidermal growth factor (EGF) family of growth factors during implantation.
Lim H; Das SK; Dey SK
Dev Biol; 1998 Dec; 204(1):97-110. PubMed ID: 9851845
[TBL] [Abstract][Full Text] [Related]
12. Growth factor receptors: structure, mechanism, and drug discovery.
McInnes C; Sykes BD
Biopolymers; 1997; 43(5):339-66. PubMed ID: 9566117
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors.
Chen FL; Xia W; Spector NL
Clin Cancer Res; 2008 Nov; 14(21):6730-4. PubMed ID: 18980964
[TBL] [Abstract][Full Text] [Related]
15. ErbB receptors and their ligands in the breast.
Zahnow CA
Expert Rev Mol Med; 2006 Sep; 8(23):1-21. PubMed ID: 16984691
[TBL] [Abstract][Full Text] [Related]
16. [Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer].
Leirdal M; Sioud M
Tidsskr Nor Laegeforen; 2002 Jan; 122(2):178-82. PubMed ID: 11873574
[TBL] [Abstract][Full Text] [Related]
17. Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure.
Doggen K; Ray L; Mathieu M; Mc Entee K; Lemmens K; De Keulenaer GW
J Mol Cell Cardiol; 2009 Jan; 46(1):33-8. PubMed ID: 19010331
[TBL] [Abstract][Full Text] [Related]
18. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
Tao RH; Maruyama IN
J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor.
Witters L; Scherle P; Friedman S; Fridman J; Caulder E; Newton R; Lipton A
Cancer Res; 2008 Sep; 68(17):7083-9. PubMed ID: 18757423
[TBL] [Abstract][Full Text] [Related]
20. Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways.
Pugatsch T; Abedat S; Lotan C; Beeri R
Breast Cancer Res; 2006; 8(4):R35. PubMed ID: 16839426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]